UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

The Future Looks Brighter After 25 Years of Retinal Gene Therapy

Auricchio, A; Smith, AJ; Ali, RR; (2017) The Future Looks Brighter After 25 Years of Retinal Gene Therapy. Human Gene Therapy , 28 (11) pp. 982-987. 10.1089/hum.2017.164. Green open access

[thumbnail of Auricchio_Future_25_years_Retinal_Gene_Therapy.pdf]
Preview
Text
Auricchio_Future_25_years_Retinal_Gene_Therapy.pdf - Accepted Version

Download (483kB) | Preview

Abstract

The first report of in vivo gene delivery to the retina dates back to 1987 when a retroviral vector was injected intraocularly in newborn mice. Later came the observation that retinal cells could be successfully transduced using adenoviral and then adeno-associated and lentiviral vectors. By 2000, it had become clear that the eye, compared to other organs and tissues, provides a number of advantages for in vivo gene therapy with regard to safety, efficacy, and route to clinical application. This has prompted the development of many successful proof-of-concept studies in animal models. The demonstration that sight could be restored in a large-animal model with a congenital form of blindness was a major landmark that opened the door to the first-in-human trials for recessively inherited blinding conditions. With these first human studies demonstrating safety as well as some efficacy, retinal gene therapy has now come of age. Rapid clinical development has highlighted various new challenges, including the treatment of patients with advanced photoreceptor degeneration or dominantly inherited retinal dystrophies and those with defects in large genes. Yet, given the progress over the last 25 years, a bright future is expected for retinal gene therapy.

Type: Article
Title: The Future Looks Brighter After 25 Years of Retinal Gene Therapy
Open access status: An open access version is available from UCL Discovery
DOI: 10.1089/hum.2017.164
Publisher version: http://dx.doi.org/10.1089/hum.2017.164
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
Keywords: eye, AAV, ocular gene therapy trials
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > Institute of Ophthalmology
URI: https://discovery.ucl.ac.uk/id/eprint/1571514
Downloads since deposit
210Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item